Publication number: 20250382261
Abstract: The present invention discloses novel pentamidine analogues such as pentamidine analogs having the general formula: wherein: X is C, N, or —CH—CH—, Y is Y1 when X is N, and Y is Y1 and Y2 when X is C, or —CH—CH—, Y1, or Y1 and Y2 independently, are selected from H, hydroxyl, lower alkyl, lower alkoxy, halogen, nitro, amino, cyano or thiol, wherein the lower alkyl or alkoxy is optionally substituted with one or more of hydroxyl, halogen, nitro, amino, cyano, thiol, or a 5- or 6-membered aromatic or non-aromatic ring, optionally substituted with one or more of hydroxyl, lower alkyl, lower alkoxy, halogen, nitro, amino, cyano or thiol, wherein Y1 is not H when X is N; or Y1 is a 5- or 6-membered aromatic or non-aromatic ring, optionally substituted with one or more groups selected from hydroxyl, lower alkyl, lower alkoxy, halogen, nitro, amino, cyano, carboxy, or thiol, and Y2 is H, if present; or Y1 and Y2 together with X form a 5- to 8-membered hydrocarbon ring, optionally substituted with one or more g
Type:
Application
Filed:
November 4, 2022
Publication date:
December 18, 2025
Applicants:
The Broad Institute, Inc., MCMASTER UNIVERSITY, THE GENERAL HOSPITAL CORPORATION
Inventors:
Deborah HUNG, Michael SERRANO-WU, Katie LEE, Brian HUBBARD, Eric BROWN, Craig MACNAIR, Maya FARHA, Jean-Philippe COTE